Ontario's CDMO Therapure to Manufacture VBI Vaccine's COVID-19 Drug, an Industrial Info Market Brief
Ontario's CDMO Therapure to Manufacture VBI Vaccine's COVID-19 Drug, an Industrial Info Market Brief
Attachment: Canada COVID vax 0820
VBI Vaccines has tapped contract development and manufacturing organisation (CDMO) Therapure Biomanufacturing to produce VBI's COVID-19 drug.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
